Literature DB >> 31807882

Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies.

Frederik A Verburg1,2, Martha Hoffmann3,4, Ioannis Iakovou3,5, Mark W Konijnenberg6,7, Jasna Mihailovic3,8,9, Pablo Minguez Gabina6,10, Petra Petranović Ovčariček3,11, Cristoph Reiners12, Alexis Vrachimis3,13, Slimane Zerdoud3,14, Luca Giovanella3,15,16, Markus Luster3,17.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31807882     DOI： 10.1007/s00259-019-04580-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  19 in total

1.  RADIOACTIVE IODINE AS AN INDICATOR IN THYROID PHYSIOLOGY. V. THE USE OF RADIOACTIVE IODINE IN THE DIFFERENTIAL DIAGNOSIS OF TWO TYPES OF GRAVES' DISEASE.

Authors:  S Hertz; A Roberts
Journal:  J Clin Invest       Date:  1942-01       Impact factor: 14.808

Review 2.  Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.

Authors:  Frederik A Verburg; Markus Dietlein; Michael Lassmann; Markus Luster; Christoph Reiners
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

3.  Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid.

Authors:  S M SEIDLIN; L D MARINELLI; E OSHRY
Journal:  J Am Med Assoc       Date:  1946-12-07

4.  Well-Founded Recommendations for Radioactive Iodine Treatment of Differentiated Thyroid Cancer Require Balanced Study of Benefits and Harms.

Authors:  Mark Tulchinsky; Richard P Baum; K G Bennet; Leonard M Freeman; Ian Jong; Kalevi Kairemo; Carol S Marcus; Renee M Moadel; Paritosh Suman
Journal:  J Clin Oncol       Date:  2018-05-03       Impact factor: 44.544

5.  Thyroid Function and Cancer Risk: The Rotterdam Study.

Authors:  Samer R Khan; Layal Chaker; Rikje Ruiter; Joachim G J V Aerts; Albert Hofman; Abbas Dehghan; Oscar H Franco; Bruno H C Stricker; Robin P Peeters
Journal:  J Clin Endocrinol Metab       Date:  2016-09-20       Impact factor: 5.958

6.  Spotlight on the Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism is Keeping the Highest Risk From Antithyroid Drugs in the Blind Spot.

Authors:  Mark Tulchinsky; A Bertrand Brill
Journal:  Clin Nucl Med       Date:  2019-10       Impact factor: 7.794

7.  DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.

Authors:  Uta Eberlein; Harry Scherthan; Christina Bluemel; Michel Peper; Constantin Lapa; Andreas Konrad Buck; Matthias Port; Michael Lassmann
Journal:  J Nucl Med       Date:  2015-11-12       Impact factor: 10.057

8.  Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine.

Authors:  R J Molenaar; C Pleyer; T Radivoyevitch; S Sidana; A Godley; A S Advani; A T Gerds; H E Carraway; M Kalaycio; A Nazha; D J Adelstein; C Nasr; D Angelini; J P Maciejewski; N Majhail; M A Sekeres; S Mukherjee
Journal:  Leukemia       Date:  2017-11-06       Impact factor: 11.528

9.  Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.

Authors:  Remco J Molenaar; Surbhi Sidana; Tomas Radivoyevitch; Anjali S Advani; Aaron T Gerds; Hetty E Carraway; Dana Angelini; Matt Kalaycio; Aziz Nazha; David J Adelstein; Christian Nasr; Jaroslaw P Maciejewski; Navneet S Majhail; Mikkael A Sekeres; Sudipto Mukherjee
Journal:  J Clin Oncol       Date:  2017-12-18       Impact factor: 50.717

Review 10.  Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies.

Authors:  Eilon Krashin; Agnieszka Piekiełko-Witkowska; Martin Ellis; Osnat Ashur-Fabian
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-13       Impact factor: 5.555
View more
  2 in total

1.  "Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide" on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news.

Authors:  Luca Giovanella; Frederik A Verburg; Petra Petranović Ovčariček; Ioannis Iakovou; Jasna Mihailovic; Alexis Vrachimis; Slimane Zerdoud; Martha Hoffmann; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06       Impact factor: 9.236

Review 2.  Current practice in patients with differentiated thyroid cancer.

Authors:  Martin Schlumberger; Sophie Leboulleux
Journal:  Nat Rev Endocrinol       Date:  2020-12-18       Impact factor: 43.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.